Panniculitis

Panniculitis is a group of diseases whose hallmark is inflammation of subcutaneous fatty and muscle tissue. Symptoms include tender skin nodules, and systemic signs such as weight loss and fatigue. (From the Wikpedia article Panniculitis.)

Download PDF

Recent Publications on Panniculitis:
Subcutaneous Sarcoidosis Masquerading as Cellulitis. Sarcoidosis is a multisystem disease encountered by general physicians as...	9th July, 2008	2nd Dermatology Department, School of Medicine, National and Kapodistrian	Dermatology. 2008 Jul 8;217(3):212-214. DOI Direct Link
Granulomatous panniculitis associated with Sjogren syndrome. Various dermatologic manifestations are observed in the different lupus...	9th July, 2008		Arch Dermatol. 2008 Jun;144(6):815-6. DOI Direct Link
A complication of mesotherapy: noninfectious granulomatous panniculitis. Various dermatologic manifestations are observed in the different lupus...	9th July, 2008		Arch Dermatol. 2008 Jun;144(6):808-9. DOI Direct Link
Idiopathic lobular panniculitis (Weber Christian disease): A case report. Weber Christian disease, an idiopathic relapsing febrile subcutaneous and...	8th July, 2008	Institute of Medicine, Tribhuvan University, Kathmandu, Nepal.	Kathmandu Univ Med J (KUMJ). 2006 Apr-Jun;4(2):243-5.
Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first? Exocrine pancreatic carcinoma is a particularly malignant neoplasm of the...	4th July, 2008		Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1211-3. DOI Direct Link
→View more research publications.

Panniculitis Clinical Trials:
Study of Pralatrexate and Gemcitabine With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Lymphoproliferative Malignancies	Relapsed or Refractory Lymphoproliferative Malignancies Interventions: Drug: (RS)-10-Propargyl-10-Deazaaminopterin;   Drug: Gemcitabine hydrochloride (HCl)

Panniculitis Patents:
US Patent No.	Title
6953682	Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
7094565	21612, novel human dehydrogenases
7094587	16002 Molecules and uses therefor
7105482	Methionine aminopeptidase-2 inhibitors and methods of use thereof
7112426	Human cAMP-dependent protein kinase beta-catalytic subunit
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Panniculitis scientists - we have details of around 239 individuals working on Panniculitis .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.